Published in Ann Thorac Surg on October 01, 2010
Multidisciplinary Oncoplastic Approach Reduces Infection in Chest Wall Resection and Reconstruction for Malignant Chest Wall Tumors. Plast Reconstr Surg Glob Open (2016) 0.83
A pilot randomized clinical study of the additive treatment effect of photodynamic therapy in breast cancer patients with chest wall recurrence. J Breast Cancer (2014) 0.81
Local recurrence involving the sternum and ribs following mastectomy and titanium mesh implants for chest wall reconstruction: A case report. Oncol Lett (2013) 0.75
Resection of Primary and Secondary Tumors of the Sternum: An Analysis of Prognostic Variables. Ann Thorac Surg (2015) 0.75
Radionecrosis 30 years after breast cancer. Indian J Surg (2014) 0.75
Invited commentary. Ann Thorac Surg (2010) 0.75
Reconstruction of Chest Wall by Cryopreserved Sternal Allograft after Resection of Aneurysmal Bone Cyst of Sternum. Case Rep Surg (2017) 0.75
Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol (2006) 1.72
Ranking and rankability of hospital postoperative mortality rates in colorectal cancer surgery. Ann Surg (2014) 1.61
20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters. Ann Surg Oncol (2011) 1.60
Prognosis of solitary fibrous tumors: a multicenter study. Ann Surg Oncol (2013) 1.51
Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol (2012) 1.51
Isolated limb perfusion with TNF-alpha and melphalan for distal parts of the limb in soft tissue sarcoma patients. J Surg Oncol (2011) 1.48
Radiotherapy for soft tissue sarcomas after isolated limb perfusion and surgical resection: essential for local control in all patients? Ann Surg Oncol (2010) 1.44
Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther (2009) 1.38
Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology (2004) 1.31
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol (2013) 1.28
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat (2002) 1.26
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. Eur J Cancer (2012) 1.18
The relationship between volume or surgeon specialty and outcome in the surgical treatment of lung cancer: a systematic review and meta-analysis. J Thorac Oncol (2012) 1.15
Optical biopsy of breast tissue using differential path-length spectroscopy. Phys Med Biol (2005) 1.14
Outcome after surgical resections of recurrent chest wall sarcomas. J Clin Oncol (2008) 1.06
The stromal part of adenocarcinomas of the oesophagus: does it conceal targets for therapy? Eur J Cancer (2010) 1.05
Outcome after therapeutic lymph node dissection in patients with unknown primary melanoma site. Ann Surg Oncol (2011) 1.03
Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer (2006) 1.03
Local and intralesional therapy of in-transit melanoma metastases. J Surg Oncol (2011) 1.03
Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. J Gastrointest Surg (2005) 0.99
Retroviral gene transfer of interferon-inducible protein 10 inhibits growth of human melanoma xenografts. Int J Cancer (2002) 0.99
Incidence and treatment of recurrent plantar fibromatosis by surgery and postoperative radiotherapy. Am J Surg (2004) 0.99
Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern. Int J Radiat Oncol Biol Phys (2008) 0.98
Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol (2010) 0.96
Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer (2003) 0.96
Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas. J Clin Oncol (2011) 0.96
Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases. Ann Surg Oncol (2010) 0.96
Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile? World J Surg Oncol (2012) 0.95
One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases. Ann Surg (2004) 0.95
Chemoradiation for esophageal cancer: institutional experience with three different regimens. Am J Clin Oncol (2011) 0.94
Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies. Eur J Cancer (2010) 0.94
Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis. Mod Pathol (2008) 0.94
Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience. Ann Surg Oncol (2010) 0.94
Efficacy of repeat isolated limb perfusions with tumor necrosis factor alpha and melphalan for multiple in-transit metastases in patients with prior isolated limb perfusion failure. Ann Surg Oncol (2005) 0.94
A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate. Eur Urol (2011) 0.94
Complications in wound healing after chest wall resection in cancer patients; a multivariate analysis of 220 patients. J Thorac Oncol (2009) 0.93
Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Anticancer Drugs (2008) 0.92
Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results. Eur Radiol (2003) 0.92
Quality improvement of pancreatic surgery by centralization in the western part of the Netherlands. Ann Surg Oncol (2011) 0.91
Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors. World J Surg (2011) 0.91
Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence. Ann Surg Oncol (2009) 0.91
Surgical management of rectal gastrointestinal stromal tumors. J Surg Oncol (2012) 0.89
Centralization of esophagectomy: how far should we go? Ann Surg Oncol (2014) 0.89
Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis. Int J Cancer (2011) 0.89
Giant solitary fibrous tumour of the liver. World J Surg Oncol (2006) 0.88
Successful and safe introduction of laparoscopic colorectal cancer surgery in Dutch hospitals. Ann Surg (2013) 0.87
Nationwide outcome registrations to improve quality of care in rectal surgery. An initiative of the European Society of Surgical Oncology. J Surg Oncol (2009) 0.87
Outcome of low-volume surgery for esophageal cancer in a high-volume referral center. Ann Surg Oncol (2009) 0.86
Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's witness. Eur J Cardiothorac Surg (2006) 0.86
Isolated limb perfusion for melanoma in-transit metastases: developments in recent years and the role of tumor necrosis factor alpha. Curr Opin Oncol (2011) 0.86
The Influence of Hospital Volume on Circumferential Resection Margin Involvement: Results of the Dutch Surgical Colorectal Audit. Ann Surg (2016) 0.85
Gastric cancer: decreasing incidence but stable survival in the Netherlands. Acta Oncol (2013) 0.84
Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma. Curr Treat Options Oncol (2007) 0.84
Effect of hospital volume on postoperative mortality and survival after oesophageal and gastric cancer surgery in the Netherlands between 1989 and 2009. Eur J Cancer (2012) 0.84
A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities. Acta Oncol (2015) 0.84
Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up. Ann Surg Oncol (2010) 0.83
Multifocal myxoid liposarcoma--metastasis or second primary tumor?: a molecular biological analysis. J Mol Diagn (2010) 0.83
Chest wall resection for internal mammary lymph node metastases of breast cancer. Breast (2009) 0.83
Safety of elective colorectal cancer surgery: non-surgical complications and colectomies are targets for quality improvement. J Surg Oncol (2013) 0.83
An unusual case of hemosiderotic fibrohistiocytic lipomatous lesion: correlation of MRI and pathologic findings. Sarcoma (2008) 0.82
Isolated limb perfusion with tumor necrosis factor and melphalan prevents amputation in patients with multiple sarcomas in arm or leg. Ann Surg Oncol (2005) 0.82
Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification. Mod Pathol (2013) 0.82
The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma. Cancer (2006) 0.82
Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol (2012) 0.82
CO2 laser treatment for regional cutaneous malignant melanoma metastases. Dermatol Surg (2015) 0.82
Improved guideline compliance after a 3-year audit of multidisciplinary colorectal cancer care in the western part of the Netherlands. J Surg Oncol (2012) 0.82
An interactive portal to empower cancer survivors: a qualitative study on user expectations. Support Care Cancer (2015) 0.81
Fifty tumor necrosis factor-based isolated limb perfusions for limb salvage in patients older than 75 years with limb-threatening soft tissue sarcomas and other extremity tumors. Ann Surg Oncol (2003) 0.81
Necrotizing pneumonitis caused by postoperative pulmonary torsion. Interact Cardiovasc Thorac Surg (2007) 0.81
Isolated limb perfusion with TNF-alpha and melphalan in locally advanced soft tissue sarcomas of the extremities. Recent Results Cancer Res (2009) 0.81
The Preceding Surgeon Factor in Bariatric Surgery: a Positive Influence on the Learning Curve of Subsequent Surgeons. Obes Surg (2015) 0.80
Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol (2005) 0.80
Evaluating the validity of quality indicators for colorectal cancer care. J Surg Oncol (2013) 0.79
Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration. J Surg Oncol (2011) 0.79
Increasing incidence and survival of a rare skin cancer in the Netherlands. A population-based study of 2,220 cases of skin adnexal carcinoma. J Surg Oncol (2013) 0.79
Prognostic factors after cervical lymph node dissection for cutaneous melanoma metastases. Melanoma Res (2005) 0.79
Partial mastectomy and m. latissimus dorsi reconstruction for radiation-induced fibrosis after breast-conserving cancer therapy. World J Surg (2011) 0.78
Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib. World J Surg Oncol (2013) 0.78
Prognostic value of mitotic index and Bcl2 expression in male breast cancer. PLoS One (2013) 0.78
[The quality indicator 'tumour positive surgical margin following breast-conserving surgery' does not provide transparent insight into care]. Ned Tijdschr Geneeskd (2010) 0.78
TNF-based isolated limb perfusion: a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas. Cancer Treat Res (2004) 0.78
Plexiform neurofibroma with intraspinal extension. J Am Coll Surg (2002) 0.78
The role of isolated limb perfusion for melanoma confined to the extremities. Surg Clin North Am (2003) 0.78
['Clinical auditing', a novel tool for quality assessment in surgical oncology]. Ned Tijdschr Geneeskd (2011) 0.76
Treatment of extremity desmoid tumours. Eur J Surg Oncol (2004) 0.75
Delineation of chondroid lipoma: an immunohistochemical and molecular biological analysis. Sarcoma (2011) 0.75
Chromosome 17 copy number changes in male breast cancer. Cell Oncol (Dordr) (2015) 0.75
Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement. Ann Surg Oncol (2009) 0.75
Multicenter Stratified Comparison of Hospital Costs Between Laparoscopic and Open Colorectal Cancer Resections: Influence of Tumor Location and Operative Risk. Ann Surg (2017) 0.75
Reduced 30-Day Mortality After Laparoscopic Colorectal Cancer Surgery: A Population Based Study From the Dutch Surgical Colorectal Audit (DSCA). Ann Surg (2016) 0.75
[The value of ipsilateral breast tumor recurrence as a quality indicator: hospital variation in the Netherlands]. Ned Tijdschr Geneeskd (2015) 0.75
Blindness: a rare and serious complication after extensive mediastinal resection. Ann Thorac Surg (2008) 0.75
Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era. Am J Clin Oncol (2015) 0.75
[A healthy young man with lost ribs]. Ned Tijdschr Geneeskd (2011) 0.75
Textbook Outcome: A Composite Measure for Quality of Elective Aneurysm Surgery. Ann Surg (2017) 0.75
Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study. World J Surg (2012) 0.75
PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study. Melanoma Res (2017) 0.75
Blue dye can be safely omitted in most sentinel node procedures for melanoma. Melanoma Res (2016) 0.75